Vinita Takiar
Head/Neck
Phase 2
Protocol NRG-CC013
Study on BMX-001 for Reducing Mouth Sores in Head and Neck Cancer Patients
This study explores if the drug BMX-001 can reduce painful mouth sores in patients undergoing chemoradiation therapy for head and neck cancer. By comparing it to a placebo, researchers aim to see if BMX-001 offers additional relief.